Elicio Therapeutics Inc.
ELTX | NASDAQ
$1.82
-$0.09 (-4.71%)
Sep 22, 2026, 12:19 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -37.84M | -40.19M | -39.57M | -45.86M | -54.61M | -51.28M | -51.9M | -46.84M | -38.67M | -38.99M | -35.2M | -32.9M | -29.43M | -29.18M | -35.39M | -13.85M | -22.35M | -32.13M | -24.08M | -67.84M | -69.81M | -73.08M |
Depreciation & Amortization | 1.14M | 1.14M | 1.13M | 1.15M | 1.15M | 1.17M | 1.18M | 1.16M | 1.14M | 1.35M | 1.17M | 511.32K | 532.32K | 31.32K | 149.32K | 745K | 668K | 874K | 698.3K | 621.3K | 545.3K | 509.3K |
Stock-Based Compensation | 3.27M | 3.05M | 2.7M | 2.39M | 2.02M | 1.66M | 1.47M | 1.34M | 1.35M | 1.28M | 1.18M | 1.04M | 811.61K | 645.61K | 578.51K | 464.59K | 354.59K | 241.59K | 430.07K | 345.38K | 345.38K | 345.38K |
Other Working Capital | -7.63M | -1.3M | -3.08M | 464K | 1.93M | 3.44M | 7.29M | 1.07M | 4.86M | 2.49M | -80K | 596.66K | -3.71M | -2.37M | -607.35K | -28.12M | -28.53M | -26.75M | -27.5M | 32.91M | 31.53M | 28.63M |
Other Non-Cash Items | 6.39M | 2.64M | 2.24M | 4.62M | 11.6M | 7.01M | 8.21M | 7.47M | -1.61M | 1.83M | 209K | 894.26K | 2.23M | 12.49M | 12.23M | 13.38M | 13.98M | 5.56M | 5.57M | 19.56M | 26.92M | 29.11M |
Deferred Income Tax | n/a | n/a | n/a | n/a | 16K | 16K | 16K | 16K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -10.66M | -5.12M | -3.45M | -1.2M | 4.74M | 6.37M | 3.96M | -1.36M | 1.65M | -2.14M | -57K | 376.74K | -4.42M | 1.46M | 516.74K | -29.65M | -31.37M | -30.05M | -28.7M | 36.1M | 24.04M | 22.88M |
Operating Cash Flow | -37.69M | -38.48M | -36.95M | -38.9M | -35.09M | -35.07M | -37.07M | -38.22M | -36.13M | -36.68M | -32.69M | -30.07M | -30.28M | -14.66M | -22.18M | -29.27M | -39.08M | -55.75M | -46.16M | -11.21M | -17.95M | -20.23M |
Capital Expenditures | -16K | -16K | -16K | -45K | -45K | -87K | -87K | -42K | -87K | -49K | -66K | -160.84K | -115.84K | -670.84K | -653.84K | -595K | -656K | -341K | -416.85K | -390.85K | -330.85K | -96.85K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 42K | 42K | 45K | 45K | 3K | 37K | 34K | 34K | 34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -16K | -16K | -16K | -45K | -45K | -87K | -84K | -39K | -84K | -12K | -32K | -126.84K | -81.84K | -670.84K | -653.84K | -595K | -656K | -341K | -416.85K | -390.85K | -330.85K | -96.85K |
Debt Repayment | n/a | n/a | n/a | 9.87M | 19.73M | 19.73M | 19.73M | 29.73M | 10M | 10M | 20M | 10M | 10M | 10.01M | n/a | 293K | 293K | 279K | 293K | n/a | 31.22M | 32.12M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -150K | n/a | n/a | n/a | 150K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -36K | -36K | -36K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 61K | 9.92M | 9.92M | 9.92M | 20.9M | 11M | 16.96M | 16.96M | -4.02M | 17.63M | 11.7M | 11.77M | 21.71M | 44.23K | 4.23K | -64K | -95K | -1.32M | -1.15M | -1.14M | -1.05M | 170.25K |
Financial Cash Flow | 38.97M | 34.39M | 36.7M | 32.06M | 53.24M | 41.63M | 42.32M | 49.1M | 18.4M | 39.6M | 38.61M | 42.79M | 51.51M | 31.26M | 21.2M | 10.43M | 2.35M | -1.29M | 3.84M | 3.64M | 34.16M | 53.59M |
Net Cash Flow | 1.2M | -4.08M | -227K | -6.72M | 18.28M | 6.53M | 5.19M | 10.83M | -17.85M | 2.91M | 5.89M | 12.59M | 21.15M | -63.92M | -81.56M | -99.34M | -117.31M | -57.45M | -42.73M | -8.26M | 20.43M | 33.57M |
Free Cash Flow | -37.71M | -38.49M | -36.97M | -38.94M | -35.13M | -35.15M | -37.16M | -38.26M | -36.22M | -36.73M | -32.76M | -30.23M | -30.39M | -15.34M | -22.83M | -29.86M | -39.73M | -56.09M | -46.58M | -11.6M | -18.29M | -20.32M |
Adj. Free Cash Flow | -40.98M | -41.54M | -39.67M | -41.33M | -37.15M | -36.81M | -38.62M | -39.6M | -37.57M | -38.01M | -33.94M | -31.28M | -31.2M | -15.98M | -23.41M | -30.32M | -40.09M | -56.33M | -47.01M | -11.95M | -18.63M | -20.67M |
Maintenance CapEx | -16K | -16K | -16K | -45K | -45K | -87K | -87K | -42K | -87K | -49K | -66K | -160.84K | -115.84K | -670.84K | -653.84K | -559K | -559K | -244K | -319.85K | -329.85K | -330.85K | -96.85K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -36K | -97K | -97K | -97K | -61K | n/a | n/a |
Owner Earnings | -37.71M | -38.49M | -36.97M | -38.94M | -35.13M | -35.15M | -37.16M | -38.26M | -36.22M | -36.73M | -32.76M | -30.23M | -30.39M | -15.34M | -22.83M | -29.82M | -39.64M | -55.99M | -46.48M | -11.54M | -18.29M | -20.32M |
Add to Watchlist
Select watchlists to add or remove ELTX